QMS Medical Allied Services Ltd
Incorporated in 2017, QMS Medical Allied Services Ltd is a manufacturer and distributor of medical devices[1]
- Market Cap ₹ 193 Cr.
- Current Price ₹ 99.8
- High / Low ₹ 122 / 71.5
- Stock P/E 15.3
- Book Value ₹ 46.5
- Dividend Yield 0.50 %
- ROCE 16.6 %
- ROE 14.4 %
- Face Value ₹ 10.0
Pros
Cons
- Promoter holding has decreased over last quarter: -5.60%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2024 | Mar 2025 | TTM | |
---|---|---|---|
122 | 156 | 172 | |
104 | 130 | 145 | |
Operating Profit | 18 | 25 | 27 |
OPM % | 15% | 16% | 16% |
0 | 2 | 2 | |
Interest | 3 | 5 | 5 |
Depreciation | 3 | 4 | 4 |
Profit before tax | 12 | 19 | 20 |
Tax % | 26% | 27% | |
9 | 14 | 14 | |
EPS in Rs | 4.66 | 6.26 | 6.54 |
Dividend Payout % | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 28% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 34% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | -7% |
1 Year: | -11% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | 14% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2024 | Mar 2025 | |
---|---|---|
Equity Capital | 18 | 18 |
Reserves | 61 | 72 |
35 | 60 | |
22 | 40 | |
Total Liabilities | 135 | 190 |
24 | 53 | |
CWIP | 2 | 3 |
Investments | 2 | 3 |
108 | 131 | |
Total Assets | 135 | 190 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2024 | Mar 2025 | |
---|---|---|
1 | 20 | |
-3 | -45 | |
0 | 26 | |
Net Cash Flow | -1 | 1 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2024 | Mar 2025 | |
---|---|---|
Debtor Days | 124 | 101 |
Inventory Days | 172 | 176 |
Days Payable | 90 | 76 |
Cash Conversion Cycle | 205 | 202 |
Working Capital Days | 148 | 100 |
ROCE % | 17% |
Documents
Announcements
-
Outcome of Board Meeting
16 October 2025 - Board approved migration from NSE Emerge (SME) to NSE Main Board on October 16, 2025.
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
15 October 2025 - Reg 74(5) SEBI certificate for quarter ended Sep 30, 2025: all shares dematted; no rematerialisation requests.
-
Shareholders meeting
30 September 2025 - AGM Sept 29, 2025: Resolutions 1–6 passed; FY2024-25 financials adopted; dividend declared; MD reappointed.
-
Shareholders meeting
29 September 2025 - AGM Sep 29, 2025: financials considered, dividend proposed, MD reappointment, auditors; voting results pending.
-
Analysts/Institutional Investor Meet/Con. Call Updates
29 September 2025 - Analyst meeting with Whitestone Financial Advisors on October 03, 2025 at 11:00 AM in Mumbai.
Annual reports
Concalls
-
Aug 2025TranscriptPPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Sep 2023Transcript PPT
Business Overview:[1]
QMASL does marketing and distribution of medical products and medical education services to clinics, pharma, medical companies and also to individual users. These devices are sold directly in the brand of the manufacturer and are sold under the brand name Q Devices. Company manages the distribution for other brands viz. 3M, Heine, Rossmax, etc.